Novabridge Biosciences ADR (NBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -208,560 | N/A | N/A | N/A | N/A |
| Depreciation Amortization | 2,246 | N/A | N/A | N/A | N/A |
| Other Working Capital | 26,544 | N/A | N/A | N/A | N/A |
| Other Operating Activity | 55,092 | 0 | 0 | 0 | 0 |
| Operating Cash Flow | $-124,678 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -4,597 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 36,772 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -1,758 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -1,657 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $30,518 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 7,182 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 14,754 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $21,936 | $N/A | $N/A | $N/A | $N/A |
| Exchange Rate Effect | 2,178 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 241,451 | N/A | N/A | N/A | N/A |
| End Cash Position | 171,405 | N/A | N/A | N/A | N/A |
| Net Cash Flow | $-70,046 | $N/A | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -124,678 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -124,678 | 0 | 0 | 0 | 0 |